GOOGL
54
3
CI
59
-4
MOS
55
5
MAT
41
-2
AVGO
30
8
UHS
58
-2
EMC
59
6
NAVI
55
-2
TGT
40
9
VRSK
80
-2
APA
25
-5
PYPL
56
13
JNPR
47
-3
CVS
52
-5
D
43
-7
UA
59
-4
MCO
80
-3
AAP
35
14
MO
60
-3
WYNN
33
-9
GOOGL
54
3
CI
59
-4
MOS
55
5
MAT
41
-2
AVGO
30
8
UHS
58
-2
EMC
59
6
NAVI
55
-2
TGT
40
9
VRSK
80
-2
APA
25
-5
PYPL
56
13
JNPR
47
-3
CVS
52
-5
D
43
-7
UA
59
-4
MCO
80
-3
AAP
35
14
MO
60
-3
WYNN
33
-9
Financhill
Back

Matthews Emerging Markets Ex Chn Act ETF Vs. Bright Minds Biosciences Industry Stock Comparison

Buy
57

MEMX
Matthews Emerging Markets Ex Chn Act ETF

Last Price:
29.70
Seasonality Move:
8.2%
Sell
25

DRUG
Bright Minds Biosciences

Last Price:
45.75
Seasonality Move:
-24.57%
Buy
57
Matthews Emerging Markets Ex Chn Act ETF (MEMX) is a Buy

Is Matthews Emerging Markets Ex Chn Act ETF a Buy, Sell or Hold?

  • The current Matthews Emerging Markets Ex Chn Act ETF [MEMX] share price is $29.85. The Score for MEMX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • MEMX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
25
Bright Minds Biosciences (DRUG) is a Sell

Is Bright Minds Biosciences a Buy, Sell or Hold?

  • The current Bright Minds Biosciences [DRUG] share price is $46.55. The Score for DRUG is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • DRUG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MEMX Stock Price Chart

What is Matthews Emerging Markets Ex Chn Act ETF's stock price today?

  • The Matthews Emerging Markets Ex Chn Act ETF share price today is $29.85
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MEMX is experiencing slight buying pressure.

DRUG Stock Price Chart

What is Bright Minds Biosciences's stock price today?

  • The Bright Minds Biosciences share price today is $46.55
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing slight selling pressure.

MEMX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.15 Sell
Relative Strength Index (14 RSI): 46.51 Sell
Chaikin Money Flow: 832 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (29.6 - 30.32) Sell
Bollinger Bands (100): (29.67 - 30.89) Sell

DRUG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.95 Buy
Relative Strength Index (14 RSI): 61.69 Buy
Chaikin Money Flow: -16145 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (37.09 - 49.25) Buy
Bollinger Bands (100): (-4.86 - 35.5) Buy

MEMX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.83 Buy
20-day SMA: 29.86 Sell
50-day SMA: 30.36 Sell
200-day SMA: 29.73 Buy
8-day EMA: 29.8 Buy
20-day EMA: 29.91 Sell
50-day EMA: 30.13 Sell
200-day EMA: 29.53 Buy

DRUG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.35 Buy
20-day SMA: 42.22 Buy
50-day SMA: 29.51 Buy
200-day SMA: 8.28 Buy
8-day EMA: 40.89 Buy
20-day EMA: 39.84 Buy
50-day EMA: 31.67 Buy
200-day EMA: 13.3 Buy

Matthews Emerging Markets Ex Chn Act ETF Earnings Growth & MEMX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Matthews Emerging Markets Ex Chn Act ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bright Minds Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):